Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

MGF Igf-1-ec

IGF-1Ec, IGF-1Eb, Mechano-Growth Factor

Quick Stats
Studies 62
Trials 100
Score 2
2013 pubmed

The E-domain region of mechano-growth factor inhibits cellular apoptosis and preserves cardiac function during myocardial infarction.

Mavrommatis. Evangelos E; Shioura. Krystyna M KM; Los. Tamara T; Goldspink. Paul H PH

Key Findings

  • The MGF E‑domain peptide is taken up by heart cells without needing the IGF‑1 receptor and moves to the nucleus.
  • It blocks the intrinsic apoptosis pathway during cellular stress, preserving mitochondrial function and preventing caspase‑3 activation.
  • In mice with induced myocardial infarction, the peptide preserves systolic and diastolic function, reduces pathological hypertrophy, and lowers apoptotic cell numbers.

Practical Outcomes

  • While the study suggests the MGF E‑domain peptide could be a future cardioprotective agent, there’s no human dosage, safety, or administration protocol yet. Biohackers should view this as early‑stage evidence and wait for clinical trials before considering any self‑experimentation.

Summary

A lab-made piece of the MGF protein can slip into heart cells, go to the nucleus, and stop the cell‑death chain that’s triggered by stress. In mice that had a heart attack, giving this peptide right away helped keep the heart pumping better and reduced harmful thickening and cell death. The work is still in cells and animals, so it’s not a ready‑to‑use hack yet, but it shows the peptide might protect the heart.

Abstract

Insulin-like growth factor-1 (IGF-1) isoforms are expressed via alternative splicing. Expression of the minor isoform IGF-1Eb [also known as mechano-growth factor (MGF)] is responsive to cell stress. Since IGF-1 isoforms differ in their E-domain regions, we are interested in determining the biological function of the MGF E-domain. To do so, a synthetic peptide analog was used to gain mechanistic insight into the actions of the E-domain. Treatment of H9c2 cells indicated a rapid cellular uptake mechanism that did not involve IGF-1 receptor activation but resulted in a nuclear localization. Peptide treatment inhibited the intrinsic apoptotic pathway in H9c2 cells subjected to cell stress with sorbitol by preventing the collapse of the mitochondrial membrane potential and inhibition of caspase-3 activation. Therefore, we administered the peptide at the time of myocardial infarction (MI) in mice. At 2 weeks post-MI cardiac function, gene expression and cell death were assayed. A significant decline in both systolic and diastolic function was evident in untreated mice based on PV loop analysis. Delivery of the E-peptide ameliorated the decline in function and resulted in significant preservation of cardiac contractility. Associated with these changes were an inhibition of pathologic hypertrophy and significantly fewer apoptotic nuclei in the viable myocardium of E-peptide-treated mice post-MI. We conclude that administration of the MGF E-domain peptide may provide a means of modulating local tissue IGF-1 autocrine/paracrine actions to preserve cardiac function, prevent cell death, and pathologic remodeling in the heart.

Study Information

Provider

pubmed

Year

2013

Date

2013-05-28T00:00:00.000Z

DOI

10.1007/s11010-013-1689-4